Aperio AT2 DX System
K-Number: K190332 · 2019-05-20
Device Summary
Frequently Asked Questions
What is the Aperio AT2 DX System?
Aperio AT2 DX System is a medical device that received FDA 510(k) clearance on 2019-05-20. The listed applicant is Leica Biosystems Imaging, Inc.. The 510(k) number is K190332.
When did Aperio AT2 DX System receive FDA 510(k) clearance?
Aperio AT2 DX System received FDA 510(k) clearance on 2019-05-20, under 510(k) number K190332.
Who is the listed applicant for Aperio AT2 DX System?
The FDA 510(k) record lists Leica Biosystems Imaging, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Aperio AT2 DX System?
The FDA product code for Aperio AT2 DX System is PSY.
Other records listing Leica Biosystems Imaging, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: PSY)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.